Related references
Note: Only part of the references are listed.An in silico approach for the discovery of CDK5/p25 interaction inhibitors
Bing Zhang et al.
BIOTECHNOLOGY JOURNAL (2011)
Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis
Jun-Li Liu et al.
MEDICAL ONCOLOGY (2011)
Using BRET to study chemical compound-induced disruptions of the p53-HDM2 interactions in live cells
Anne Mazars et al.
BIOTECHNOLOGY JOURNAL (2010)
Inhibiting the Cyclin-Dependent Kinase CDK5 Blocks Pancreatic Cancer Formation and Progression through the Suppression of Ras-Ral Signaling
Georg Feldmann et al.
CANCER RESEARCH (2010)
Cyclin-dependent kinase inhibitors: a survey of recent patent literature
Herve Galons et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie Crews et al.
HUMAN MOLECULAR GENETICS (2010)
A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation
Ya-Li Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA
Vincent B. C. Tan et al.
JOURNAL OF MOLECULAR MODELING (2010)
A toxin-antitoxin module as a target for antimicrobial development
Virginia S. Lioy et al.
PLASMID (2010)
Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke Models
Benedicte Menn et al.
PLOS ONE (2010)
Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics
Lindsay O. Kirkland et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Identification of potential cellular targets of aloisine A by affinity chromatography
Caroline Corbel et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
ATP-Noncompetitive Inhibitors of CDK-Cyclin Complexes
Mar Orzaez et al.
CHEMMEDCHEM (2009)
Biosensing and imaging based on bioluminescence resonance energy transfer
Zuyong Xia et al.
CURRENT OPINION IN BIOTECHNOLOGY (2009)
β-Arrestin-Based Bret2 Screening Assay for the Non-β-Arrestin Binding CB1 Receptor
Milka Vrecl et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
The BRET technology and its application to screening assays
Johan Bacart et al.
Biotechnology Journal (2008)
An unusual member of the Cdk family: Cdk5
Fatema A. Dhariwala et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2008)
Protein Folding Activity of Ribosomal RNA Is a Selective Target of Two Unrelated Antiprion Drugs
Deborah Tribouillard-Tanvier et al.
PLOS ONE (2008)
Extraneuronal roles of cyclin-dependent kinase 5
Jesusa L. Rosales et al.
BIOESSAYS (2006)
Oligomerization of the yeast α-factor receptor -: Implications for dominant negative effects of mutant receptors
Austin U. Gehret et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions
Kevin D. G. Pfleger et al.
NATURE PROTOCOLS (2006)
Mammalian cyclin-dependent kinases
M Malumbres et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Roscovitine targets, protein kinases and pyridoxal kinase
S Bach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based β-arrestin2 recruitment assay
FF Hamdan et al.
JOURNAL OF BIOMOLECULAR SCREENING (2005)
Yeast as a model for medical and medicinal research
WH Mager et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Development of a BRET2 screening assay using β-arrestin 2 mutants
M Vrecl et al.
JOURNAL OF BIOMOLECULAR SCREENING (2004)
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles
JC Cruz et al.
NEURON (2003)
Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers
C Couturier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells via distinct mechanisms
R Emter et al.
FEBS LETTERS (2002)
Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer
MA Ayoub et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neurotoxicity induces cleavage of p35 to p25 by calpain
MS Lee et al.
NATURE (2000)
Share Paper
